Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

Author： Hakimi A. Ari   Ostrovnaya Irina   Jacobsen Anders   Susztak Katalin   Coleman Jonathan A.   Russo Paul   Winer Andrew G.   Mano Roy   Sankin Alexander I.   Motzer Robert J.   Voss Martin H.   Offit Kenneth   Purdue Mark   Pomerantz Mark   Freedman Matthew   Choueiri Toni K.   Hsieh James J.   Klein Robert J.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|122|3|402-410

ISSN： 0008-543X

Source： Cancer, Vol.122, Iss.3, 2016-02, pp. : 402-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma

By Haddad Ahmed Q.   Kapur Payal   Singla Nirmish   Raman Jay D.   Then Matthew T.   Nuhn Philipp   Buchner Alexander   Bastian Patrick   Seitz Christian   Shariat Shahrokh F.   Bensalah Karim   Rioux-Leclercq Nathalie   Sagalowsky Arthur   Lotan Yair   Margulis Vitaly  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 43-50

Blackwell Publishing

Access to resources Recommend Favorite

Lapatinib and renal cell carcinoma

By Gross-Goupil Marine   Bernhard Jean-Christophe   Ravaud Alain  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite

Therapy for Non-Clear Cell Histologies in Renal Cancer

By  

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

By  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1752-1753

Blackwell Publishing

Access to resources Recommend Favorite

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

By Joseph Richard W.   Kapur Payal   Serie Daniel J.   Eckel-Passow Jeanette E.   Parasramka Mansi   Ho Thai   Cheville John C.   Frenkel Eugene   Rakheja Dinesh   Brugarolas James   Parker Alexander  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1059-1067

Blackwell Publishing

Access to resources Recommend Favorite